Month: September 2011

The interaction of Pediatric Dentistry with other specialities

|

Editora Santos launches Odontopediátrica Interaction: a multidisciplinary overview , work that discusses the interaction of Pediatric Dentistry with other specialties of dentistry.

fully illustrated, didactic and easy handling, the book shows children facing clinical procedures, interacting with prevention, orthodontics, preventive psychology applied to the child, radiology, Endodontics, prosthetics, surgery and dentistry, as well as aspects related to patients with special needs

.

the work is directed to clinical dental surgeons and specialists in Pediatric Dentistry, as well as undergraduate and graduate level mainly specialization

.

 

Service Odontopediátrica Title: Interaction – a multidisciplinary overview authors: John Bausells, Sosigenes Victor Benfatti and Maristela Honorius Cayetano 1st/2011 Edition: Quantity of pages: 382 R $

Price: 220.00

www.grupogen.com.br

 

Read More

NASA is closely monitoring satellite expected to impact on the land on 23 September

|

Washington, 16 sep (EFE).-La NASA is closely following the trajectory of the satellite’s research of the high atmosphere (UARS), he retired from performance in 2005 and said today he expects that it impacts on the Earth the next 23 of September.

Space shuttle “Discovery” transported in 1991 this six-ton satellite designed to measure atmospheric changes and effects of pollution, which embarked on his way back to Earth is six years.

NASA scientists calculate that the satellite despedazará into the atmosphere but claimed that, although not disintegrate all his pieces, the odds that can jeopardize citizens is “extremely small”.

In this sense indicated that the likelihood that a space object wounds a person during its re-entry is less than one in 10,000.

In fact, they claim that any case in which a person by a space during the re-entry manoeuvre object has been injured has not been confirmed since the beginning of the space age

La NASA follows the trajectory of the satellite together with other foreign space agencies and report on the movement of the space object as you get closer to the Earth.

Scheduled arrive in late September or early October but according to explained the scientists expect before arrival due to a sharp increase in solar activity this week. EFE

elv/mv/dmt

Read More

The number of new cases of cholera in Haiti fell by 50 per cent in August

|

Port-au-Prince, 16 sep (EFE).-the number of new cases of cholera in Haiti fell by 50 per cent in August, placed in 20.093 from the 40.873 recorded in July, reported today the Mission of the United Nations for the stabilization of Haiti (Minustah).

. The spokesperson of the Office for the coordination of Humanitarian Affairs (OCHA) United Nations, Emmanuelle Schneider, noted that the number of deaths has also fallen “in a meaningful way” during that period, since that has gone from 376 deaths in July to 298 in August

Addition, the whole of the ten departments in Haiti recorded a decrease in the mortality rate, which in the country as a whole is now 1.4 percent.

The cholera epidemic, declared in mid-October of last year, has caused the death of 6.266 people and affected 439.604, according to the latest report published by the Ministry of health in Haiti, dated August 29.

However, according to OCHA, in Léogâne, Gressier, Petit Goâve and Grand Goâve (Western Department) there was an increase of 20 per cent of cases of cholera due to heavy rains recorded from 5 to September 12.

Members of various locations warned of cases of the disease emerged in recent days, some of them fatal, as occurred in Bainet, where at least five people were killed, according to sources parliamentary.

The departmental direction of health of the Department of South-East intends to set medium-and long-term projects to install 50 points oral hydration and three units of treatment of cholera, among other initiatives, according to OCHA.

The statement highlights the rapid response of the Haitian authorities with the support of humanitarian partners and donors, who have been disbursed since the beginning of year $ 107 million to combat the epidemic, representing 97 percent of the 110 million requested initially for this purpose.

The epidemic of cholera, declared in mid-October of last year, has caused the death of 6.266 people and affected 439.604, according to the latest report published by the Ministry of health of Haiti. EFE/file

Read More

Shorter treatment helps some patients with hepatitis C

|

New YORK (Reuters Health) – manage Peginterferon and ribavirin for 24 weeks after completing treatment combined with telaprevir is as effective as the regime of 48 weeks to cure chronic infection by the virus of hepatitis C (HCV), according to a new Studio.

Reduce the duration of treatment reduces the risk of adverse effects, but only in patients who respond quickly to the initial phase of treatment, publishes a team in the New England Journal of Medicine internet Edition.

“In our study, two-thirds (65 percent) patients were candidates to receive shorter therapy due to its extended rapid viral response.” “Were they could have indicated Peginterferon and ribavirin for 24 weeks”, said the lead author, Dr. Kenneth Sherman, of the school of Medicine of the University of Cincinnati.

The study of non-inferiority was designed to confirm that patients with the fourth and twelfth weeks not detectable HCV RNA evolved not worse with an abbreviated system of therapy with Peginterferon and Ribavirin, combined in a first stage with telaprevir.

Vertex Pharmaceutical

and Tibotec funded study ILLUMINATE. The administration of food and medicines of United States (FDA for its acronym in English) approved telaprevir may last.

The study began with the selection of volunteers from Belgium, the Netherlands and the United States genotype 1 HCV carriers. None had been treated prior.

A 540 was told to take 12 weeks of treatment with telaprevir (750 mg every eight hours), Peginterferon alfa-2a (180 mcg per week) and Ribavirin (1,000-1,200 mg per day), most combination of Peginterferon and Ribavirin during other 12 weeks.

One hundred patients left the initial phase of treatment (including 12 which made him by virological failure, 62 by adverse effects and 12 because they refused to continue the treatment or withdrawn consent).

Of 440 volunteers who continued in the study, 322 were extended rapid virological response: HCV RNA kept undetectable in the blood at 20 weeks. Randomly, stated them stopping treatment to reach 24 weeks or continue it another 24 weeks.

92 Percent of the 162 with extended rapid virological response ending treatment at 24 weeks was still free of virus to 48 weeks.

The 88 percent of the 160 remaining, who continued therapy with Peginterferon and ribavirin for another 24 weeks, remained a virological response sustained at 48 weeks. In this group, 41 left 24 weeks of treatment.

On the other hand, 64 percent of 118 patients without rapid response with other 24 weeks of treatment, had a sustained virological response. Thirty-nine of them suspended treatment.

Total, 72 percent responded quickly to the regime of three drugs to the fourth week. 12 Weeks, 65 per cent remained traces of the virus in the body

In the essay ILLUMINATE, 18 per cent of volunteers treatment was withdrawn by the adverse effects: anaemia by 39 per cent of the patients (by 6 per cent of the cases was serious and 32 participants needed transfusions) and rash in 37 percent of patients (5 per cent was serious).

Most of the cases of rash appeared in the first eight weeks of treatment.

Serious adverse effects were more common in the group treated for 48 weeks with Peginterferon and Ribavirin. (The rate was 10 percent, compared with 2 percent of patients with limited treatment).

Fatigue was the most common secondary effect (68 percent), followed by pruritus (51 percent), nausea (47 percent), anemia (39 percent), headaches (38 percent), insomnia (32 per cent), diarrhoea (28 percent) and disease type influenza (26 percent), it was reported the team.

The traditional 48 weeks of Peginterferon and Ribavirin therapy costs about $30,000, said Sherman. But the telaprevir is more expensive. “I saw figures of $49,000,” indicated.

“This is a lot of money for a short treatment, but must be compared with the costs to society of hepatitis C without trying, in which even a liver transplant could cost hundreds of thousands of dollars, not to mention previous transplant associated medical costs,” finished Sherman.

Source: New England Journal of Medicine, September 2011

Read More

Malaria vaccine provides little protection: study

|

New YORK (Reuters Health) – an experimental vaccine against malaria proved to be not effective in field trials, except when the participants were infected with a specific strain of the parasite that causes the disease.

The study carried out in Mali revealed 48.4 percent of cases of malaria among 199 African children vaccinated and a 54.4 per cent of cases in 201 children immunized against rabies as a placebo (control group). The difference was not statistically significant.

But Dr Christopher Plowe, of the school of Medicine of the University of Maryland, in Baltimore, found that the results published in the New England Journal of Medicine, internet Edition are encouraging because the vaccine should attack the parasite in the blood, the stadium in which appear the symptoms.

“En.” the first time that a blood-stage vaccine offers some level of protection against clinical malaria “Attenuates the stadium that causes illness and death”, expressed.

Plowe explained that the species of the parasite against which the vaccine proved most promising represents between 3 and 12 per cent of cases of malaria.

In addition to this vaccine, developed at the Institute of research of the Army Walter Reed in United States, and known as FMP2.1/AS02 (A), there are other 17 vaccines against malaria are being tested, according to the World Health Organization (who).

The who estimates that there are 247 million cases of malaria in the world and 718.000 deaths per year.

Malaria is the leading cause of death and disease in Mali. The team assessed 745 children aged between 1 and 6. 400 Participants received at least one intramuscular doses (at 367 them were three doses). The injections were applied with monthly intervals and 383 children is them he controlled six months more in the season of malaria.

“Vaccine not provided a high level of protection against clinical malaria, but according to secondary outcomes would be effective for a species of parasite,” advises the team. Not attributed deaths or adverse effects serious.

In a previous trial, the vaccine, for the clone 3D7 of the species Plasmodium falciparum, had elevated levels of antibodies in blood

The National Institute of Allergy and infectious diseases, national institutes of health and the United States Defense Department funded the study.

Source: New England Journal of Medicine, online September 2011

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips